Health & Nutrition
Eli Lilly shares surge on a beat-and-raise, proving the...
Eli Lilly entered Thursday well off its highs. A blowout quarter shows the market...
FDA proposes excluding Novo, Lilly weight loss drugs from...
If that proposal is finalized, the exclusion would likely limit the mass compounding...
More than 20,000 people are taking Eli Lilly's weight loss...
Eli Lilly's weight loss pill launch has been closely watched after the successful...
NDMA: A Cancer-Causing Contaminant in Meds and Meat
Billion-dollar drugs have been pulled from the market for less carcinogenic contamination...
Merck beats quarterly estimates on strength of Keytruda...
Merck narrowed its 2026 sales guidance and hiked its adjusted profit outlook.
Pharma bets a little-known form of cholesterol will underpin...
Novartis, Amgen and Eli Lilly are betting that slashing levels of a particularly...
Spotify teams up with Peloton to launch global fitness...
Spotify teams with Peloton to launch fitness content, potentially opening new revenue...
Intellia Therapeutics says its Crispr-based treatment succeeds...
Intellia Therapeutics said its Crispr-based treatment for hereditary angioedema...
FDA fast-tracks psychedelic drug research following Trump...
It's a big shift toward supporting psychedelic-based medicines for treatment-resistant...
Cramer says look to these 4 stocks to go with your high-flying...
CNBC's Jim Cramer urged investors to look beyond the market's high-flying names...
.jpg&h=630&w=1200&q=100&v=477daa9eb8&c=1)
